Seoul Pharma Co. Ltd - Asset Resilience Ratio

Latest as of March 2025: 9.30%

Seoul Pharma Co. Ltd (018680) has an Asset Resilience Ratio of 9.30% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Seoul Pharma Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩6.64 Billion
≈ $4.50 Million USD Cash + Short-term Investments

Total Assets

₩71.39 Billion
≈ $48.38 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Seoul Pharma Co. Ltd's Asset Resilience Ratio has changed over time. See 018680 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Seoul Pharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Seoul Pharma Co. Ltd (018680) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩5.66 Billion 7.93%
Short-term Investments ₩979.26 Million 1.37%
Total Liquid Assets ₩6.64 Billion 9.30%

Asset Resilience Insights

  • Limited Liquidity: Seoul Pharma Co. Ltd maintains only 9.30% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Seoul Pharma Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Seoul Pharma Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd
SHG:600351
Drug Manufacturers - Specialty & Generic 0.27%
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 6.43%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 6.40%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%

Annual Asset Resilience Ratio for Seoul Pharma Co. Ltd (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Seoul Pharma Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 10.53% ₩7.54 Billion
≈ $5.11 Million
₩71.62 Billion
≈ $48.54 Million
-4.74pp
2023-12-31 15.27% ₩9.66 Billion
≈ $6.55 Million
₩63.31 Billion
≈ $42.90 Million
-3.52pp
2022-12-31 18.79% ₩11.73 Billion
≈ $7.95 Million
₩62.43 Billion
≈ $42.31 Million
-3.41pp
2021-12-31 22.20% ₩13.82 Billion
≈ $9.37 Million
₩62.25 Billion
≈ $42.19 Million
-0.94pp
2020-12-31 23.14% ₩15.06 Billion
≈ $10.21 Million
₩65.09 Billion
≈ $44.11 Million
+12.33pp
2019-12-31 10.81% ₩7.67 Billion
≈ $5.19 Million
₩70.89 Billion
≈ $48.04 Million
+1.72pp
2018-12-31 9.09% ₩8.23 Billion
≈ $5.58 Million
₩90.57 Billion
≈ $61.38 Million
+4.00pp
2017-12-31 5.09% ₩4.43 Billion
≈ $3.00 Million
₩86.93 Billion
≈ $58.91 Million
-5.35pp
2016-12-31 10.45% ₩9.67 Billion
≈ $6.55 Million
₩92.54 Billion
≈ $62.71 Million
+10.19pp
2012-12-31 0.25% ₩153.00 Million
≈ $103.69K
₩60.68 Billion
≈ $41.12 Million
--
pp = percentage points

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$22.28 Million
₩32.88 Billion KRW
Market Cap Rank
#24673 Global
#1823 in Korea
Share Price
₩2820.00
Change (1 day)
-0.70%
52-Week Range
₩2400.00 - ₩3835.00
All Time High
₩17976.69
About

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms o… Read more